Can IL-2R alpha be a valuable marker along with CA 19-9 in the diagnosis of chronic pancreatitis and pancreatic cancer?


Kayhan B., Kayhan B., Akdogan M.

INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS, vol.19, no.3, pp.196-202, 2004 (Journal Indexed in SCI) identifier identifier identifier

  • Publication Type: Article / Article
  • Volume: 19 Issue: 3
  • Publication Date: 2004
  • Doi Number: 10.5301/jbm.2008.2455
  • Title of Journal : INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
  • Page Numbers: pp.196-202

Abstract

Background: Pancreatic cancer is characterized initially by non-specific abdominal symptoms followed by rapid tumor progression. Although chronic pancreatitis is a benign disorder, it can be one of the causative factors of pancreatic cancer. The level of the tumor marker carbohydrate antigen 19-9 (CA 19-9) in pancreatic cancer does not correlate with the stage of the neoplasm. Soluble interleukin 2 receptor (sIL-2R) is a cytokine that shows increased levels during some inflammatory processes and malignant disorders.